Top 12 Clinical Research Organisations (CROs) in 2023
Feb 23, 2023 · The global clinical trials market was estimated to be worth $38.7 billion in 2021 and is expected to reach £52 billion by 2026. In this article, we look at the top 12 CROs in the world, highlighting the companies driving this considerable growth and accelerating research and development across the globe.. ICON. Recognised as the world’s largest and most comprehensive CRO powered by ...
Biosimilars Market Role in Reducing Healthcare Costs and …
Dec 9, 2024 · The global biosimilars market is witnessing remarkable growth, driven by factors such as cost efficiency, increased demand for accessible healthcare solutions, and the expiration of patents for branded biologic drugs. With a market that was valued at approximately USD 20.4 billion in 2021, the biosimilars market is expected to expand significantly, reaching more than USD 85 billion by the end ...
PharmiWeb.com: The Heart of Life Sciences on the Web
PharmiWeb.com - Global pharma news from the pharmaceutical industry, biotech, clinical research, life science & healthcare. Pharma Events Listings, Pharma Company Directory & pharma jobs.
Ottimo Pharma Emerges from Stealth with Backing from Medicxi …
Oct 28, 2024 · · David Epstein, formerly CEO of Seagen, joins as Chair & Chief Executive Officer · Mehdi Shahidi, previously SVP and Chief Medical Officer at Boehringer Ingelheim, joins as Head of Development & Chief Medical Officer · James Sabry, ex-Head of Pharma Partnering at Roche, joins the Board as Vice-Chair [28 October 2024]: [London, UK/ Boston, US]: Ottimo Pharma, a private biotech company ...
UK Regulator MHRA Grants Nanomerics Clinical Trials …
Nov 18, 2024 · LONDON, UNITED KINGDOM / ACCESSWIRE / November 18, 2024 / Nanomerics Ltd., a private speciality pharmaceutical company announced that it had received clinical trials authorisation for its first in human OC134 trial from the Medicinal and Healthcare Products Regulatory Agency (MHRA), the UK regulator. This means that the trial of OC134 in human subjects may now proceed.
Arctoris and SpiroChem Enter into Strategic Partnership to …
Oct 3, 2024 · Partnership creates integrated solution and aims to streamline biology and chemistry drug discovery processes for biotechnology and pharmaceutical companies worldwideOxford, UK, Boston, USA and Basel, Switzerland. 03 October 2024 Arctoris, a leading contract research organisation (CRO) advancing drug discovery...
Protagonist Announces Positive Topline Results From Phase 3 …
Nov 18, 2024 · ICONIC-LEAD achieved its co-primary endpoints of PASI-90 and IGA of 0 or 1 at week 16; 74% of patients achieved clear or almost clear skin (IGA 0/1) at week 24ICONIC-TOTAL achieved its primary endpoint of IGA score of 0 or 1 at week 16 in patients with plaque psoriasis in difficult-to-treat areas...
Pharmaceutical Market Size Expands Driven by Integration of …
Dec 12, 2024 · The Pharmaceutical Market, valued at an impressive USD 1.5 trillion in 2022, is poised for remarkable growth, with projections estimating it to reach USD 2.8 trillion by 2032.This represents a steady compound annual growth rate (CAGR) of 6.4% from 2023 to 2032. This article delves into the competitive landscape, growth prospects, key drivers, restraints, and regional insights shaping this ...
Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated ...
Paris, October 25, 2024Q3 sales growth of 15.7% at CER and business EPS(1) of €2.86Dupixent sales up 23.8% to €3,476 million; full-year 2024 target of ~€13 billion confirmedPharma launches up 67.1% to €727 million, led by ALTUVIIIO, Nexviazyme and RezurockVaccines sales up 25.5%, boosted by phasi...
Naobios and Sumagen successfully optimize HIV vaccine …
Oct 29, 2024 · Key milestone reached within expected initial timelines with successful set up of cell growth and production of HIV-1 vaccine candidate at bench scalePhase I/II trial to assess safety and efficacy expected to start after cGMP production end of 2025 Nantes, France October 29, 2024 – Naobios, a CDMO (Contract Developm...